Publications
Since 2013, our team has published widely about the development of deprescribing guidelines, our knowledge mobilization approaches and implementation in practice. This list provides quick links to all of our publications.
Author(s): Farrell B, Rousse-Grossman J, Santamaria C, McCarthy LM. (2023, March)
Title: Applying the Behaviour Change Wheel to support deprescribing in long-term care: Qualitative interviews with stakeholder participants.
Journal: Exploratory Research in Clinical and Social Pharmacy
Doi: 10.1016/j.rcsop.2023.100256
Author(s): Farrell B, McCarthy L, Famiyeh I, Conklin J, Cranley L, Raman-Wilms L. (2023, February)
Title: Measuring the usefulness and impact of “Talking about Medications” workshop.
Journal: Canadian Pharmacists Journal
Doi: 10.1177/17151635231153382
Author(s): Farrell B, Raman-Wilms L, Sadowski CA, Mallery L, Turner J, Gagnon C, Cole M, Grill A, Isenor JE, Mangin D, McCarthy L, Schuster B, Sirois C, Sun W, Upshur R. (2023, February)
Title: Canadian Deprescribing Network Healthcare Providers Education Committee. A proposed curricular framework for an interprofessional approach to deprescribing.
Journal: Medical Science Educator
Doi: 10.1007/s40670-022-01704-9
Author(s): Conklin J, Farrell B, Dilliott D, Richardson L, McCarthy L, Raman-Wilms L. (2022, December)
Title: Community engagement in a disengaged world: development and implementing educational workshops on deprescribing amid the COVID-19 pandemic.
Journal: Canadian Pharmacists Journal
Doi: 10.1177/17151635221139830
Author: Farrell B, Lass E, Moayyedi P, Ward D, Thompson W. (2022, October)
Title: Reduce unnecessary use of proton pump inhibitors.
Journal: BMJ
Doi: 10.1136/bmj-2021-069211
Author: Gnjidic D, Johansson M, Muscat Meng D, Farrell B, Langford A, Reeve E. (2022, October)
Title Achieving sustainable healthcare through deprescribing.
Journal: Cochrane Database of Systematic Reviews.
Doi: 10.1002/14651858.ED000159
Author: McCarthy LM, Savage R, Dalton K, Mason R, Li J, Lawson A, Wu W, Sternberg S, Byrne S, Petrovic M, Onder G, Cherubini A, O’Mahony D, Gurwitz J, Pegreffi F, Rochon PA. (2022, September)
Title: ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people.
Journal: Drugs and Aging
Doi: 10.1007/s40266-022-00964-9
Author(s): Farrell B, Galley E, Jeffs L, Howell P, McCarthy L. (2022, September)
Title: “Kind of blurry”: Deciphering clues to prevent, investigate and manage prescribing cascades.
Journal: PLOS ONE
Doi: 10.1371/journal.pone.0272418
Author(s): McCarthy L, Farrell B, Howell P, Quast T. (2022, August).
Title: Supporting deprescribing in long-term care: An approach using stakeholder engagement, behavioural science and implementation planning.
Journal: Exploratory Research in Clinical and Social Pharmacy
Doi: 10.1016/j.rcsop.2022.100168
Author(s): Farrell B, Grant R, Dilliott D, Granikov V, Sen HE, Grad R, Vuong V, Smith S, Pluye P. (2022, July).
Title: Lessons learned from using whiteboard videos and YouTube for deprescribing guidelines knowledge mobilization.
Journal: International Journal of Pharmacy Practice
Doi: 10.1093/ijpp/riac054
Author(s): Farrell B. (2022, March).
Title: Part 1: Interactive case: rational deprescribing of benzodiazepine receptor agonists for insomnia.
Journal: Journal of the American College of Clinical Pharmacy.
Doi: 10.1002/jac5.1612
Author(s): Farrell B, Dilliott D, Richardson L, Conklin J, McCarthy L, Raman-Wilms L. (2022, March).
Title: “Talking about your medications” – a workshop series aimed at helping older adults participate in conversations about their medications.
Journal: Canadian Pharmacists Journal
Doi: 10.1177/17151635221076075
Author(s):McCarthy L, Deng Z, Thompson W, Korenvain C, Lega I, Farrell B, Lochnan H. (2021).
Title: Benefits and harms of deprescribing antihyperglycemics for adults with type 2 diabetes: a systematic review.
Journal: Canadian Journal of Diabetes.
Doi: 10.1016/j.jcjd.2022.01.009
Author(s): Mangin D, Lamarche L, Agarwal G, Banh HL, Dore Brown N, Cassels A, Colwill K, Dolovich L, Farrell B, Garrison S, Gillett J, Griffith LE, Holbrook A, Jurcic-Vrataric J, McCormack J, O’Reilly D, Raina P, Richardson J, Risdon C, Savelli M, Sherifali D, Siu H, Tarride JE, Trimble J, Ali A, Freeman K, Langevin J, Parascandalo J, Templeton JA, Dragos S, Borhan S, Thabane L. (2021).
Title: Team Approach to Polypharmacy Evaluation and Reduction: Study Protocol for a Randomized Controlled Trial.
Journal: BioMedCentral Trials
Doi: 10.1186/s13063-021-05685-9
Author(s): Galley E, Farrell B, Conklin J, Howell P, McCarthy L, Raman-Wilms L. (2021).
Title: Using community engagement to initiate conversations about deprescribing in primary care.
Journal: Journal of Community Engagement and Scholarship.
Link: https://jces.ua.edu/articles/10.54656/jces.v15i1.447
Author(s): Farrell B, Clarkin C, Conklin J, Dolovich L, Irving H, McCarthy L, Raman-Wilms L. (2020).
Title: Community pharmacists as catalysts for Deprescribing: an exploratory study using quality improvement processes.
Journal: Canadian Pharmacists Journal
Doi: 10.1177/1715163519882969
Author(s): Farrell B, Grad R, Howell P, Quast T, Reeve E. (2020).
Title: Deprescribing Guidelines: Value of an Interactive Mobile Application.
Journal: PRiMER
Doi: 10.22454/PRiMER.2020.349237
Author(s): Farrell B, Jeffs L, Irving H, McCarthy LM. (2020).
Title: Patient and provider perspectives on the development and resolution of prescribing cascades: a qualitative study.
Journal: BMC Geriatrics
Doi: 10.1186/s12877-020-01774
Author(s): Thompson W, Reeve E, Moriarty F, Maclure M, Turner J, Steinman MA, Conklin J, Dolovich L, McCarthy L, Farrell B. (2019).
Title: Deprescribing: future directions for Research.
Journal: Research in Social and Administrative Pharmacy
Link: https://www.sciencedirect.com/science/article/pii/S1551741118307757
Author(s): Lee JY, Farrell B, Holbrook AM. (2019).
Title: Deprescribing benzodiazepine receptor agonists taken for insomnia: a review and key messages from practice guidelines.
Journal: Polish Archives of Internal Medicine
Doi: 10.20452/pamw.4391
Author(s): Greiver M, Dahrouge S, O’Brien P, Manca D, Lussier MT, Wang J, Burge F, Grandy M, Singer A, Twohig M, Moineddin R, Kalia S, Aliarzadeh B, Ivers N, Garies S, Turner JP, Farrell B. (2019).
Title: Improving care for elderly patients living with polypharmacy: protocol for a pragmatic cluster randomized trial in community based primary care practices in Canada.
Journal: Implementation Science
Doi: 10.1186/s13012-019-0904-4
Author(s): Raman-Wilms L, Farrell B, Sadowski C, Austin Z. (2019)
Title: Deprescribing: an educational imperative.
Journal: Research in Social and Administrative Pharmacy
Link: https://www.sciencedirect.com/science/article/pii/S1551741118307745
Author(s): Thompson W, Reeve E, Moriarty F, Maclure M, Turner J, Steinman MA, Conklin J, Dolovich L, McCarthy L, Farrell B. (2019)
Title: Deprescribing: future directions for research.
Journal: Research in Social and Administrative Pharmacy
Author(s): Conklin J, Farrell B, Suleman S. (2019).
Title: Implementing deprescribing guidelines into frontline practice: Barriers and facilitators.
Journal: Research in Social and Administrative Pharmacy
Link: https://www.sciencedirect.com/science/article/abs/pii/S1551741118307526?via%3Dihub
Author(s): Raman-Wilms L, Farrell B, Sadowski C, Austin Z. (2019).
Title: Deprescribing: an educational imperative.
Journal: Research in Social and Administrative Pharmacy
Link: https://pubmed.ncbi.nlm.nih.gov/30241871/
Author(s): Farrell B, Conklin J, Dolovich L, Irving H, Maclure M, McCarthy L, Moriarty F, Pottie K, Raman-Wilms L, Reeve E, Thompson W. (2019).
Title: Deprescribing Guidelines: an international symposium on development, implementation, research and health professional education.
Journal: Research in Social and Administrative Pharmacy
Link: https://www.sciencedirect.com/science/article/pii/S1551741118307447
Author(s): Thompson W, Farrell B, Welch V, Tugwell P, Way C, Richardson L, Bjerre L. (2019).
Title: Continuation or deprescribing of proton pump inhibitors: A consult patient decision aid.
Journal: Canadian Pharmacists Journal
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346337
Author(s): Moriarty F, Pottie K, Dolovich L, McCarthy L, Rojas-Fernandez C, Farrell B**. (2019).
Title: Deprescribing Recommendations: an essential consideration for clinical guideline developers.
Journal: Research in Social and Administrative Pharmacy
Link: https://www.sciencedirect.com/science/article/pii/S1551741118307770
Author(s): Reeve E, Farrell B, Thompson W, Herrmann N, Sketris I, Magin P, Chenoweth L, Gorman M, Quirke L, Bethune G, Forbes F, Hilmer S. (2018).
Title: Evidence-based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine.
Journal: University of Sydney.
Link: http://sydney.edu.au/medicine/cdpc/resources/deprescribing-guidelines.php
Author(s): Farrell B, Thompson W, Black C, Archibald D, Raman-Wilms L, Grassau P, Patel T, Weaver L, Eid K, Winslade N. (2018).
Title: Healthcare providers’ roles and responsibilities in management of polypharmacy: Results of a modified Delphi.
Journal: Canadian Pharmacists Journal
Doi: 10.1177%2F1715163518804276
Author(s): Turner JP, Richard C, Lussier MT, Lavoie ME, Farrell B, Roberge D, Tannenbaum C. (2018).
Title: Deprescribing Conversations: a closer look at prescriber-patient communication.
Journal: Therapeutic Advances in Drug Safety
Doi: 10.1177%2F2042098618804490
Author(s): Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, Holbrook A, Boyd C, Swenson R, Ma A, Farrell B. (2018).
Title: Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice Guideline.
Journal: Canadian Family Physician
Link: https://www.cfp.ca/content/64/5/339
Author(s): Farrell B, Richardson L, Raman-Wilms L, de Launay D, Alsabbagh MW, Conklin J. (2018)
Title: Self-efficacy for deprescribing: a survey for health care professionals using evidence-based deprescribing guidelines.
Journal: Research in Social and Administrative Pharmacy
Doi: 10.1016/j.sapharm.2017.01.003
Author(s): Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, Raman-Wilms L, Rojas-Fernandez C, Sinha S, Thompson W, Welch V, Wiens A. (2018).
Title: Deprescribing antipsychotics for behavioural and psychological symptoms of dementia (BPSD) and insomnia: Evidence-based clinical practice guideline.
Journal: Canadian Family Physician
Link: https://www.cfp.ca/content/cfp/64/1/17.full.pdf
Author(s): Thompson W, Black C, Welch V, Farrell B, Bjerre LM, Tugwell P. (2018)
Title: Patient values and preferences surrounding proton pump inhibitor use: a scoping review.
Journal: Patient
Doi: 10.1007/s40271-017-0258-4
Author(s): Tannenbaum C, Farrell B, Shaw J, Morgan S, Trimble J, Currie J, Turner J, Rochon P, Silvius J. (2017).
Title: An ecological approach to reduce the use of potentially inappropriate medications in Canada: the Canadian Deprescribing Network.
Journal: Canadian Journal on Aging
Doi: 10.1017/S0714980816000702
Author(s): Reeve E, Thompson W, Farrell B. (2017).
Title: Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action.
Journal: European Journal of Internal Medicine
Doi: 10.1016/j.ejim.2016.12.021
Author(s): Farrell B, Black C, Thompson W, McCarthy L, Rojas-Fernandez C, Lochnan H, Shamji S, Upshur R, Bouchard M, Welch V. (2017)
Title: Deprescribing antihyperglycemic agents in older persons: an evidence-based clinical practiced guideline.
Journal: Canadian Family Physician
Link: https://www.cfp.ca/content/63/11/832
Author(s): Farrell B, Pottie K, Thompson W, Boghossian T, Pizzola L, Rashid FJ, Rojas-Fernandez C, Walsh K, Welch V, Moayyedi P. (2017)
Title: Deprescribing proton-pump inhibitors: an evidence based clinical practice guideline.
Journal: Canadian Family Physician
Link: https://www.cfp.ca/content/63/5/354
Author(s): Boghossian TA, Rashid FJ, Welch V, Thompson W., Rojas-Fernandez C., Moayyedi P, Pottie K, Pizzola L, Walsh K, Farrell B. (2017)
Title: Deprescribing versus continuation of chronic proton pump inhibitor use in adults.
Journal: Cochrane Database of Systematic Reviews
Doi: 10.1002/14651858.CD011969.pub2
Author(s): Thompson W, Farrell B, Welch V, Tugwell P, Bjerre LM. (2017)
Title: Should I continue taking my acid reflux medication? Design of a pilot before/after study evaluating a patient decision aid.
Journal: Canadian Pharmacists Journal
Doi: 10.1177/1715163516679425
Author(s): Black C, Thompson W, Welch V, McCarthy L, Rojas-Fernandez C, Lochnan H, Shamji S, Upshur R, Farrell B (2016)
Title: Lack of evidence to guide deprescribing of antihyperglycemics: a systematic review.
Journal: Diabetes Therapy
Doi: 10.1007/s13300-016-0220-9
Author(s): Thompson W, Hogel M, Li Y, Thavorn K, O’Donnell D, McCarthy L, Dolovich L, Black C, Farrell B. (2016)
Title: Effect of a proton-pump inhibitor deprescribing guideline on drug usage and costs in long-term care.
Journal: Journal of the American Medical Directors Association
Doi: 10.1016/j.jamda.2016.04.020
Author(s): Thompson W, Quay TAW, Rojas-Fernandez C, Farrell B, Bjerre LM. (2016)
Title: Atypical antipsychotics for insomnia: a systematic review.
Journal: Sleep Medicine
Doi: 10.1016/j.sleep.2016.04.003
Author(s): Farrell B, Pottie K, Rojas-Fernandez C, Bjerre LM, Thompson W, Welch V. (2016)
Title: Methodology for developing deprescribing guidelines: using evidence and GRADE to guide recommendations for deprescribing.
Journal: PLoS One
Doi: 10.1371/journal.pone.0161248.
Author(s): Thompson W, Quay T, Tang J, Bjerre L, Farrell B. (2015)
Title: Atypical antipsychotics for insomnia: a systematic review and meta-analysis protocol.
Journal: PROSPERO
Link: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=17748
Author(s): Boghossian T, Rashid J, Welch V, Boghossian TA, Moayyedi P, Pottie K, Rojas-Fernandez C, Thompson W, Welch V, Walsh K, Farrell B. (2015)
Title: Deprescribing versus continuation of chronic proton pump inhibitor use in adults (Protocol).
Journal: Cochrane Libr
Link: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011969.pub2/full
Author(s): Black C, Thompson W, Lochnan H, Lochnan H, Upshur R, McCarthy L, Rojas-Fernandez C, Shamji S, Bouchard M, Farrell B. (2105)
Title: Benefits and harms of deprescribing versus continuing antihyperglycemics for treatment of Type 2 Diabetes Mellitus: a systematic review protocol.
Journal: PROSPERO
Link: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015025727
Author(s): Conklin J, Farrell B, Ward N, McCarthy L, Irving H, Raman-Wilms L. (2015)
Title: Developmental evaluation as a strategy to enhance the uptake and use of deprescribing guidelines: protocol for a multiple case study.
Journal: Implementation Science
Doi: 10.1186/s13012-015-0279-0
Author(s): Farrell B, Tsang C, Raman-Wilms L, Irving H, Conklin J, Pottie K. (2015)
Title: What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified Delphi process
Journal: PLoS One
Doi: 10.1371/journal.pone.0122246